In nipple-sparing mastectomy with immediate implant-based reconstruction, which factor is the STRONGEST contraindication to nipple preservation?
- A Tumor located in the upper outer quadrant
- B Subareolar tumor location or nipple involvement on imaging ✓
- C Grade 2 invasive ductal carcinoma
- D BRCA1 carrier undergoing risk-reduction mastectomy
Explanation
Subareolar tumor location or evidence of nipple-areola complex involvement on imaging (nipple retraction, skin changes, MRI enhancement within 2 cm of nipple) are the strongest contraindications to nipple-sparing mastectomy because the risk of residual cancer in the retained nipple-areola complex is unacceptably high. Intraoperative frozen section of the nipple base is routinely performed; if positive, the nipple must be excised. BRCA1 carriers undergoing risk-reduction mastectomy are not contraindicated from nipple sparing if the genetic risk itself is the indication, as the nipple carries no known disease.
Reference: Bailey & Love's Short Practice of Surgery, 27th ed.
High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP
Written and medically reviewed by the StethoPrep medical team.